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Abstract.  To investigate the role of the G-CSF recep- 
tor (G-CSFR) in mediating the action of G-CSF, 
WEHI-3B D  § murine myelomonocytic leukemia cells 
were transfected with a plasmid containing the murine 
G-CSFR gene. Overexpression of G-CSFR in trans- 
fected clones was demonstrated by northern blotting, 
binding of [125I]rhG-CSF and cross-linking experi- 
ments. A high level of expression of the G-CSFR did 
not promote or suppress cellular proliferation or initi- 
ate differentiation; however,  exposure of transfected 
cells to G-CSF in suspension culture caused a large 
percentage of the population to enter a differentiation 
pathway,  as determined by two markers of the mature 
state, the ability of cells to reduce nitroblue tetrazo- 
lium (NBT)  and to express the differentiation antigen 
Mac-1  (CDllb) on the cell surface. Thus, upon treat- 
ment with 10 ng/ml of G-CSF, 60%  or more of trans- 
fected cells exhibited NBT positivity; whereas, in con- 
trast, nontransfected ceils exhibited only 6%  NBT 
positivity in response to G-CSF.  An eightfold increase 
in Mac-1 expression over that of the parental line was 
also observed in transfected cells exposed to G-CSF. 
The growth rate of the transfected clones was de- 
creased by exposure to G-CSF, presumably due to ter- 
minal differentiation. The findings suggest that the pre- 
dominant function of G-CSF and its receptor in 
WEHI-3B D  + cells is to mediate differentiation and 
that the level of the G-CSFR portion of the signal 
transduction mechanism in this malignant cell line is 
important for a response to the maturation inducing 
function of the cytokine. 
RANULOCYTE  colony-stimulating  factor  (G-CSF) ~ 
regulates  the  proliferation  and  differentiation  of 
granulocytic progenitor  cells, and stimulates func- 
tional activities and survival of mature granulocytes (see re- 
view references 18, 22, 23, 39, 40). Administration of  G-CSF 
causes  a  rapid  increase  in peripheral  blood  neutrophils; 
therefore, the cytokine has been used in clinical trials with 
patients who are myelosuppressed as a result of cancer che- 
motherapy, irradiation therapy, or bone marrow transplanta- 
tion (20, 31). Colombo et al. (8) have shown that introduction 
of the G-CSF gene into colon adenocarcinoma  C-26 cells 
suppresses  the  tumorigenicity  of these  cells  through  the 
recruitment and targeting of neutrophilic granulocytes to the 
G-CSF-releasing  cells.  G-CSF  also inhibits the metastatic 
spread  of hematogenous  and nonhematogenous  tumors  in 
mice (15). 
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G-CSF receptor (G-CSFR) is expressed predominantly in 
normal  progenitor  and mature  neutrophils  and in various 
myeloid leukemia cells (1, 24-26, 28). Some nonhematopoi- 
etic cells,  such as human endothelial,  placental and carci- 
noma cells, have also been shown to express the G-CSFR (3, 
6, 33). The murine receptor has been purified from NFS60 
cells and has a mol wt of 100,000-130,000 (10, 11). 
WEHI-3B D  + murine myelomonocytic leukemia cells ex- 
press a low level of  G-CSF receptors as determined by north- 
ern hybridization (11) and [~25I]G-CSF binding (25) experi- 
ments.  Semisolid  cultures  of WEHI-3B  D  § cells  formed 
granulocytic colonies in the presence of  G-CSF; suppression 
of the clonogenicity of these cells was accompanied by mor- 
phological changes in the colonies (5,  16). Similar effects 
were also observed with M1 and HL-60 leukemia cells (2, 
32). These findings suggest that G-CSF is an inducer of the 
differentiation of these leukemia cells.  Some investigators, 
however, have recently reported that G-CSF does not induce 
the  differentiation  of WEHI-3B  D  + (4)  and  HL-60  (36) 
cells, but is required for the survival of mature progeny (4). 
Because only one receptor has been found that specifically 
binds G-CSF, it is assumed that the biological effects of the 
cytokine  are mediated through the interaction of  G-CSF with 
the receptor. For this reason,  we have investigated the role 
of the G-CSFR in regulating the growth and differentiation 
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level  of  G-CSFR  expression  in  WEHI-3B  D §  cells  was 
elevated by transfection with an expression vector containing 
the G-CSFR gene and the effects  of overexpression of the 
G-CSFR on cellular proliferation and differentiation were de- 
termined. Although parental WEHI-3B D § cells responded 
poorly if at all to the inducing activity of G-CSF, the expres- 
sion of excess levels of the G-CSFR in cells transfected with 
this gene resulted in the attainment of the mature phenotype 
in a large percentage of cells after exposure to the cytokine. 
Materials and Methods 
Cell Culture and Differentiation 
WEHI-3B  D + leukemia cells and clones derived therefrom were main- 
tained in suspension culture in McCoy's 5A modified medium supplemented 
with 15% FBS (GIBCO Laboratories, Grand Island, NY) at 37"C in a hu- 
midified atmosphere of 95 %  air/5 %  CO2.  Exponentially growing cells 
were treated with inducers of  differentiation in fresh culture medium to initi- 
ate  maturation.  Cell  numbers  were  determined daily  using  a  particle 
counter (Model ZM, Coulter Electronics, Inc., Hialeah, FL) connected to 
a channelyzer model 256 (Coulter Electronics, Inc.). 
Clonal  growth and differentiation of WEHI-3B  D + cells were deter- 
mined using soft agar culture. Briefly, 250 cells were suspended in 3 ml of 
0.3% agar in McCoy's 5A medium containing 20%  FBS with or without 
G-CSF and cultured for 6 d. Classification of the differentiation status of 
colonies was accomplished  by the methodology of Metcalf (16) using an in- 
verted microscope. 
The ability of cells to reduce nitroblue tetrazolium (NBT)  was used as 
a functional marker of differentiation. One ￿  104 cells were collected by 
centrifugation at 300 g  for 5 rain and resospended in  1 ml of FBS-free 
medium containing 0.1% NI~ and 2 ttM  12-O-tetradecannylphorbol 13- 
acetate. The suspension was incubated at 37"C for 30 rain with shaking and 
the percentage of cells with blue-black formazan deposits was determined 
on 200 consecutive cells. 
The level of the differentiation marker Mac-1 (CD1 lb) antigen on the cell 
surface was also analyzed by indirect immnnofluorescent staining and flow 
cytometry. One x  106 ceils were collected by centrifugation at 300 g for 
5 rain, washed once with PBS, and then incubated with 100 #1 of rat anti- 
Mac-1 monoclonal antibody at a final concentration of 10/~g/ml in PBS con- 
taining 0.1% BSA on ice for 30 min. Unbound antibody was removed by 
washing cells twice with PBS containing 0.1% BSA. Cells were then stained 
with 100 #1 of affinity-purified, phyceerythdn-conjugated goat anti-rat IgG 
antibody at a final concentration of 25 #g/ml in PBS containing 0.1% BSA 
on ice for 30 min. Cells were then washed twice, and the amount of bound 
antibody was quantified using a FACS IV flow cytometer (Becton-Dickin- 
son Immunoeytometry Systems, San Jose, CA). Excitation of the fluoro- 
chrome was achieved at 488 nm with a Spectra-Physics 2025 argon ion laser 
(Spectra-Physics, Mountain View, CA). The phyceerythrin emission was 
collected through a 575/22 nm land pass filter (Omega Optical, Brattleboro, 
VT). Twenty thousand cells were observed for each sample. 
Construction of Expression Plasmids Containing the 
G-CSFR Gene 
Because the cDNA of the G-CSFR gene in the plasmid pBLJ17  (kindly 
provided by Dr. Shigakagu Nagata, Osaka Bioscience Institute, Japan) has 
no polyadenylation signal, the G-CSFR gene with its natural start and stop 
codons was released from the plasmid with XbaI digestion and subeloned 
into the XbaI site of pRe/RSV 0nvitrogan, San Diego, CA). The BmHI 
fragment containing the G-CSFR eDNA plus the bovine growth hormone 
polyadenylation signal was cut out with the BamHI restriction enzyme from 
the resulting plasmid pRGR2, and then cloned into the BamHI site of the 
vector p75/15v,  which was derived from If/5/15  (a gift from Dr.  Ulrich 
Rtither,  European Molecular Biology Laboratory, Germany) by removing 
the c-fos DNA fragment. The final resulting plasmid pGR'/-2 contained the 
bacterial neo gene with an SV40 promoter, which conferred resistance to 
the antibiotic G-418 in eukaryotic cells; the human metallothionein pro- 
moter, under which the expression of the G-CSFR gene may be stimulated 
by the treatment of cells with cadmium; and part of the polyoma virus early 
region sequence, including the origin of replication, the promoter, the en- 
hancer, and 40% of the amino terminal of the large T antigen coding se- 
quence, which has been shown to be sufficient for immortalization of mu- 
rine fibroblasts (29). 
Transfection and Single Cell Cloning 
Exponentially growing cells were washed with PBS, and resuspended in 
PBS at a density of 1  x  107 ceUs/ml. Eight  x  106 cells were incubated 
with 15/zg of lineafized plasmid DNA for 10 min and transfected by elec- 
troporation using a Bio-Rad Gene Pulser  TM (BioRad Laboratories, Hercules, 
CA) apparatus at 625 V/cm. 10 min later, cells were seeded in McCoy's 5A 
modified medium supplemented with 15% FBS. G-418 was added at a con- 
centration of 400 #g/ml after  16 h.  Transfected cells were enriched by 
G-418 selection for tv~ weeks. Single cells were then cloned using a FACS 
IV flow cytometer which placed single cells in each well of 96-well plates 
and the resulting single cell clones were expanded in multiwell plates. 
Northern Hybridization 
Total  cellular RNA was isolated from 2  ￿  106 cells using the guanidine 
thiocyanate/acid phenol method described by Chomczynski and Sacchi (7), 
separated by 1% agarose gel electrophoresis, transferred onto G-eneScreen 
membranes (New England Nuclear/DuPont, Boston, MA) and hybridized 
with [ct-32p]dCTP-labeled  eDNA probes. 
Radiolabeling of Recombinant Human G-CSF 
(rhG-CSF) 
Mutant rhG-CSF, Tyrl,3-rhG-CSF (donated by Kirin Brewery Co. Ltd., Ja- 
pan) (37), in which thrconine-1  and leucine-3 were replaced with tyrosine 
residues, was radioiodinated to 2-6 ￿  104 cpm/ng of protein using IODO- 
GEN (Pierce Chemical Co., Rockford, IL). 5 #g of Tyrl,3-rhG-CSF was 
incubated with 500/~Ci of Nal~I in 300 tA of PBS on ice for 15 rain in 
a glass tube coated with 10/~g of IODO-GEN. The iodinated Tyrl,3-rhG- 
CSF was separated from unbound Na12~I by gel filtration on a PD-10 column 
equilibrated with HBSS containing 0.2% BSA and 0.02%  Tween-20. 
Binding of  [Uq]rhG-CSF to Cells 
For each assay, 2  ￿  106 cells were collected, washed with binding medium 
(HBSS containing 20 mM Hepes, pH 7.4,  and 10% FBS), resuspended in 
binding medium and incubated with various concentrations of [12~I-IrhG- 
CSF in the absence or presence of a 100-fold excess of unlabeled rhG-CSF 
in a total volume of 100 #1 at 15~  for 3 h. The cell suspension was then 
layered on 300 #1 of FBS in a microcentrifuge tube and centrifuged at 500 g 
for 2 min at 4~  The supernatant was removed by aspiration and the tube 
was cut off just above the cell pellet. The radioactivity of the pellet was 
quantified using an LKB Compugamma Counter (Pharmacia/LKB Biotech- 
nology, Inc., Piscataway,  NJ). Specific binding was obtained by subtracting 
the radioactivity observed in the presence of unlabeled rhG-CSF from the 
radioactivity obtained in the absence of unlabeled rhG-CSE 
Chemical Cross-linking of [Uq]rhG-CSF to 
Its Receptor 
Binding of [125I]rhG-CSF  to  cells was carried out as described above. 
Briefly,  107 cells were incubated with 4 nM [12~l]rhG-CSF in the absence 
or presence of a lO0-fold concentration of unlabeled rhG-CSF in a total of 
300/11  of binding medium. After incubation, the complex of [125I]rhG- 
CSF and its receptor was cross-linked by disuceinimidyl suberate and disuc- 
cinimidyl tartarate and a cell extract was obtained by the methodology of 
Fugunaka et al. (10). The proteins present in 10/~l of the extract were sepa- 
rated on a 5-20% gradient polyacrylamide gel in the presence of SDS. The 
gel was then dried and exposed to x-ray film for 2-4 d at -80~  with inten- 
sifying screens. 
Results 
Expression of G-CSFR mRNA in Transfected Clones 
Exponentially growing WEHI-3B D § cells were transfected 
with  linearized  pGR7-2  by  electroporation.  The  vector 
p75/15v,  which was the same as pGR7-2 but devoid of the 
G-CSFR  and the bovine growth hormone polyadenylation 
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Figure 1. Expression of G-CSFR mRNA in WEHI-3B D  § clones 
transfected with pGR7-2. Total cellular RNA from cells grown in 
the absence or presence of 50/zM CdCI2 was isolated and hybrid- 
ized with 32P-radiolabeled probes for the G-CSFR and glyceralde- 
hyde pbosphate-3-debydrogenase  (GAPD) genes. The position of 
the endogenous G-CSFR mRNA is indicated by an arrow. D+V3 
and  D+GR2-14 represent  WEHI-3B D  + clones transfected  with 
the control plasmid and pGR7-2, respectively. 
Comps-,^- 
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signal,  was employed in parallel as a  control.  Transfected 
cells were enriched by selection with 400 #g/ml of G-418 
and single cell clones were obtained by flow cytometry. The 
G-418 resistant clones were expanded and 13 pGR7-2 trans- 
fected  clones,  designated  D+GR2-14,  were  randomly 
selected  for characterization.  The  expression  of G-CSFR 
mRNA was examined in these clones by northern hybridiza- 
tion. Total cellular RNA was isolated from each clone, sepa- 
rated on  formaldehyde agarose gels,  transferred to Gene- 
Screen membranes and hybridized with a  G-CSFR cDNA 
probe  (Fig.  1).  Human  glyceraldebyde-3-phosphate dehy- 
drogenase (GAPD) cDNA obtained from the American Type 
Culture Collection (Rockville, MD) was used as a control. 
The levels of G-CSFR mRNA differed in the various clones, 
but all of these cell lines,  except D+GR12,  showed an in- 
creased level of G-CSFR mRNA compared to the control 
D+V3,  which  represents  WEHI-3B  D +  cells  transfected 
with  the  control  plasmid  p75/15v.  Endogenous  G-CSFR 
mRNA was barely detectable in  the  D+V3  clone and  re- 
quired prolonged exposure. As expected, the size of the ex- 
ogenous G-CSFR mRNA was slightly smaller than that of 
the endogenous G-CSFR mRNA. Because the human metal- 
lothionein  promoter  is  leaky  and  the  treatment  of these 
clones with cadmium under the experimental conditions em- 
ployed did not increase the levels of G-CSFR mRNA, subse- 
quent binding experiments were carried out in the absence 
of cadmium. 
Specific Binding of  p'I]rhG-CSF to 
Transfected Clones 
To  determine  whether  exogenously  expressed  G-CSFR 
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l~gure 2. Specific binding of [~25I]rhG-CSF  to G-CSFR transfected 
clones. (a) Comparison of the specific rhG-CSF binding capacity 
of WEHI-3B D  + clones transfected with pGR7-2. Two x  106 cells 
were incubated with 1 nM of [n5I]rhG-CSF for 3 h at 15"C in the 
absence or presence of excess cold rhG-CSE The specific binding 
of [t25I]rhG-CSF was obtained by subtracting nonspecifically bound 
radioactivity from the total amount bound. Data are the average of 
duplicate  determinations  and the experiment  was repeated  three 
times with similar results being obtained. (b) Competition between 
[nSI]rhG-CSF binding and other  cytokines.  Two  x  106 D+GR6 
cells were incubated with  [125I]rhG-CSF in the absence or pres- 
ence of  cold rhG-CSF (100 ng), recombinant murine GM-CSF (100 
ng), IL-3 (500 U), or erythropoietin (400 U) for 3 h at 15"C. Each 
value represents the average of triplicate determinations  +  SD. 
mRNA is translated into a functional G-CSFR protein, and 
to examine the relationship between the level of the G-CSFR 
and  cellular  proliferation  and  differentiation,  the  specific 
[125I]rhG-CSF  binding  capacities of the  transfected clones 
were determined (Fig. 2 a). Two ￿  10  ~  cells of each clone 
were incubated with 1 nM [nSI]rhG-CSF in the absence or 
presence  of a  100-fold  excess  of cold  rhG-CSF  and  the 
specific  binding  was  calculated.  Vector  transfected  cells 
(D+V3) exhibited the same level of G-CSFR expression as 
the parental WEHI-3B D + cells. In contrast, pGR7-2 trans- 
fected clones exhibited a 5- to 16-fold increase in [125I]rhG- 
CSF  specific binding,  except for clone  12,  which  had an 
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Figure 3.  Binding characteristics  of [~IlrhG-CSF to WEI-II-3B 
D  § (a) and D+GR6 cells (b). Cells were incubated with various 
concentrations  of labeled ligands in the absence or presence of a 
100-fold excess of unlabeled rhG-CSF for 3 h at 15~  Each value 
is the mean of triplicate  determinations. 
mRNA level and an [~25I]rhG-CSF binding capacity essen- 
tially equivalent to that of D+V3 cells. In general, the level 
of specific binding of G-CSF approximated the increase in 
G-CSFR mRNA in the various clones.  The binding of the 
rhG-CSF to transfected cells appeared to be specific, since 
neither  recombinant  murine  GM-CSF,  IL-3,  or  erythro- 
poietin  were  significantly competitive with  [~25I]rhG-CSF, 
whereas  unlabeled  rhG-CSF  was  an  effective competitor 
(Fig. 2 b). To further characterize the binding of []2SI]rhG- 
CSF to the G-CSFR transfected clones, cells were incubated 
with [~z~I]rhG-CSF at various concentrations with or with- 
out cold rhG-CSE Fig. 3 illustrates the binding characteris- 
tics of [nSI]rhG-CSF to WEHI-3B D § parental  and clone 
D+GR6 cells.  Partial  saturation of [125I]rhG-CSF  binding 
was  observed  in  WEHI-3B  D §  cells  but  not  in  D+GR6 
ceils even at a concentration of 6,000 pM. This is probably 
due to the high levels of expression of the G-CSFR, because 
both clones showed essentially the same level of nonspecific 
binding  of the  cytokine.  Scatchard  analysis  revealed  that 
WEHI-3B D § cells have ,o6,000 binding sites per cell for 
Figure 4. Chemical cross-linking of G-CSF to its receptor in WEHI- 
3B D  § (lanes 1 and 2) and D+GR6 (lanes 3 and 4) cells.  Cells 
were incubated with 4 nM [12SI]rhG-CSF in the absence 0anes 1 
and 3) or the presence (lanes 2 and 4) of excess cold rhG-CSF at 
4~  for 4 h. The complex of []~I]rhG-CSF and the G-CSF recep- 
tor cross-linked by disuccinimidyl suberate and disuccinimidyl tar- 
tarate was analyzed on a 5-20% gradient polyacrylamide gel in the 
presence of SDS. Molecular  standards are shown in kD. 
Tyrl,3-rhG-CSF, with a dissociation constant of 5.2 nM. Be- 
cause saturation was not achieved with D+GR6 cells,  the 
number of  binding sites per cell and the dissociation constant 
could  not be determined by this method.  However, when 
D+GR6 cells were incubated with 3  nM of [~25I]rhG-CSF 
in the presence of 5-128 nM unlabeled rhG-CSF in a dis- 
placement assay, Scatchard analysis showed ,o44,000 bind- 
ing sites per D+GR6 cell, with a dissociation constant (6.0 
nM) similar to that of parental WEHI-3B D § cells. 
Chemical Cross-linking of  p25  I]rhG-CSF 
to the G-CSFR 
The level of expression and the size of the G-CSFR mole- 
cules in WEHI-3B D § cells and in D+GR clones were also 
determined by chemical cross-linking to ascertain whether 
the exogenous G-CSFR mRNA was translated into a  full- 
length protein, thereby allowing a more effective assessment 
of the role of the G-CSFR in the proliferation and differentia- 
tion of these cells.  Clone D+GR6 and WEHI-3B D § cells 
were incubated with [~25I]rhG-CSF and the bound [125I]rhG- 
CSF  was  cross-linked  to  its  receptor  by  disuccinimidyl 
suberate and  disuccinimidyl  tartarate.  The  [~25I]rhG-CSF- 
receptor complex was analyzed on a 5-20% gradient poly- 
acrylamide gel in the presence of SDS (Fig. 4). In parental 
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Figure 5. Effects of the overexpression of the G-CSFR on cellular 
proliferation. Cells were seeded at 1.3 x  104 ceils/ml and growth 
was monitored daily for 3 d in the presence of  various agents. D+V, 
vector transfected ceils (a); D+GR, pGR7-2 transfected cells (b); 
Cd, 50 ~M cadmium chloride; G, 10 ng/ml of  rhG-CSF; RA, 7 #M. 
cells, two major bands were observed, one with a mol wt of 
20,000,  which corresponds to free radioiodinated G-CSF, 
and the other with a mol wt of 195,000,  which corresponds 
to the G-CSF-receptor complex. After subtraction of  the mol 
wt of  the ligand, the size of the G-CSFR in parental cells was 
estimated to be 175 kD.  Two minor bands were also seen 
when the gel was exposed for a longer period of time; a 38- 
kD band,  which probably represents the dimeric form of 
[125I]rhG-CSF, and  an  83-kD  band  whose  identity is  un- 
known. D+GR6 cells showed the same band pattern as that 
of parental WEHI-3B D § cells, confirming that the entire 
G-CSFR  protein  was  synthesized  from  the  exogenous 
G-CSFR gene in transfected cells. The level of the G-CSFR, 
however, was ,'ol0-fold higher in the D+GR6 clone than in 
parental cells as determined by densitometry. This finding 
Table L  Clonal differentiation  of WEHI-3B D +  and 
D + GR6 Cells Induced by rhG-CSF* 
Cell line  rhG-CSF  UD  PD  D 
% 
WEHI-3B  D +  -  90(142)  8(12)  2(3) 
+  44(49)  30(33)  26(29) 
D+GR6  -  92(150)  6(9)  2(4) 
+  0(0)  0(0)  100(37) 
* 250 cells per plate were incubated in soft agar medium with or without 10 
ng/ml of rhG-CSF for 6 d. The number of colonies were counted and classified 
as a percentage of total colonies as described in Materials and Methods. The 
values in parentheses represent the mean colony number of three plates. UD, 
undifferentiated; PD,  partially differentiated; D,  differentiated. 
is  consistent with the  increased level of G-CSFR mRNA 
present in this clone. 
Effects of G-CSFR Expression on Cellular Growth 
and Differentiation 
Because  northern  hybridization,  [~25I]rhG-CSF  binding, 
and chemical cross-linking experiments have shown that a 
full-length functional G-CSFR is expressed from the exoge- 
nous G-CSFR gene in transfected clones, it was appropriate 
to evaluate the effects of the overexpression of the G-CSFR 
gene on cellular proliferation and differentiation. WEHI-3B 
D § ceils were transfected with either pGR7-2 or the control 
vector, selected with G-418, then treated with 50 #M cad- 
mium chloride,  10 ng/ml of rhG-CSF, 7/~M retinoic acid 
(RA), or combinations thereof, and their effects on cellular 
growth were measured (Fig.  5).  Untreated pGR7-2  trans- 
fected cells (D+GR) had a growth rate similar to that of vec- 
tor transfected control cells (D+V), indicating that overex- 
pression  of  the  G-CSFR  itself  does  not  promote  the 
proliferation of these cells.  Cadmium treatment decreased 
the growth rate slightly, presumably as a result of cytotoxic- 
ity produced by the metal ion. Treatment of D+V cells with 
rhG-CSF did not result in a decrease in the growth rate; how- 
ever,  when D+GR  cells were exposed to rhG-CSF,  only 
52 % of the rate of growth of untreated cells was observed. 
The combination of G-CSF and cadmium decreased cellular 
replication of D+GR cells to 34% of that of untreated cells 
(68 % inhibition of growth), whereas this treatment resulted 
in only 26%  inhibition of growth in D+V ceils.  RA,  em- 
ployed as a control, markedly depressed the growth of both 
D+V and D+GR cells to a similar degree. 
The effects of  G-CSF on the colony morphology of  WEHI- 
3B D § cells have been studied in semisolid culture (5,  16). 
The methodology employed in these investigations was used 
to evaluate the effects of the overexpression of the G-CSFR 
on the colony morphology of WEHI-3B D § cells.  In this 
system (16), colonies were classified as "undifferentiated" if 
they consisted of a tight aggregate of cells without outlying 
elements, or as "~artially differentiated" if they possessed a pe- 
ripheral halo of  loosely dispersed ceils around the central ag- 
gregate. Differentiated colonies were composed entirely of 
a  loosely dispersed collection of cells.  In the  absence of 
G-CSF, "~,90% of WEHI-3B D § or D+GR6 colonies were 
undifferentiated (Table I). Exposure to 10 ng/ml of rhG-CSF 
caused approximately 26 % of WEHI-3B D § colonies to ex- 
hibit a  differentiated phenotype, while all of the D+GR6 
colonies  were  fully  differentiated.  Fewer  colonies  were 
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Transfected  (D + V), and rhG-CSFR Transfected (D + GR) 
Cells Determined by NBT Positivity* 
Cell line  Treatment$  NBT positivity 
%w 
WEHI-3B D  +  None  0.5  +  0.5 
Cd  1.0  +  0.5 
rhG-CSF  4.5  +  2.5 
Cd+rhG+CSF  6.0  +  3.0 
RA  49.0  +  4.0 
D+V  None  2.1  +  1.6 
Cd  4.8  +  2.1 
rhG-CSF  6.3  +  4.6 
Cd+rhG-CSF  12.8  +  3.8 
RA  52.8  +  1.3 
D+GR  None  1.8  +  0.9 
Cd  4.0  +  1.5 
rhG-CSF  60.0  +  12.7 
Cd+rhG-CSF  72.4  •  8.4 
RA  62.0  •  3.0 
* Differentiation was assessed after cells were exposed to various treatments 
for3 d. 
Cd, 50/~M CdCI2; rhG-CSF, 10 ng/ml of rhG-CSF; Cd+rhG-CSF, 50/zM 
CdCl2 plus 10 ng/ml of rhG-CSF; RA, 7 ~M. 
w  Each value is the average of three independent experiments + SD. 
formed from WEHI-3B  D § (71%  of untreated ceils) and 
many fewer from D+GR6 cells (only 23 % of untreated cells) 
when exposed to rhG-CSF, even though about the same num- 
ber of colonies were formed from both cell lines in the ab- 
sence of rhG-CSE  This finding demonstrates that overex- 
pression of the G-CSFR resulted in a decrease in cell growth 
in response to the cytokine. This is consistent with the de- 
crease in the growth rate of D+GR cells exposed to G-CSF 
in suspension culture (Fig. 5). 
Considering the high local cell density in the developing 
colonies in soft agar culture, which allows for cell communi- 
cation as a short-range signal through extensive cell to cell 
contact, the differentiation observed might not be induced by 
G-CSF, but might be due to a spontaneous event caused by 
an autoerine mechanism which occurs at high cell density as 
suggested by some investigators (4). To determine whether 
the increased differentiation of the transfected cells in soft 
agar culture was directly due to the overexpression of the 
G-CSFR, the effects of the overexpression of the receptor 
was determined at the lower cell density that exists in suspen- 
sion culture, with differentiation being assayed in a relatively 
short period of rime (i.e.,  3  d  instead of the 6  d  used in 
the soft agar culture) using two different markers of the ma- 
ture state, the ability of cells to reduce NBT and the level of 
Mac-1 expression. WEHI-3B D § cells were transfected with 
pGRT-2 and selected with G-418, and the entire population 
of transfected cells (D+GR) was exposed to rhG-CSF at 10 
ng/ml.  Both parental ceils and those transfected with the 
p75/15v vector alone were used as controls; neither of these 
controls  exhibited  significant  spontaneous  differentiation 
(Table ID. The pGRT-2 transfected cells (D+GR) exhibited 
similar behavior in the absence of rhG-CSE These findings 
indicate  that  overexpression of the  G-CSFR  itself is  not 
sufficient to initiate maturation, and contrasts with the c-Jun 
protein, where overexpression in WEHI-3B D + cells trig- 
gers the differentiation process (13).  When G-CSFR trans- 
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Figure 6. Expression of  the differentiation antigen Mac-1 on the sur- 
face membrane of D+V(a) and D+GR (b) cells. Cells were treated 
with 10 ng/ml of  rhG-CSF for 3 d and stained with monoclonal anti- 
Mac-1 and phycoerythrin-conjugated goat anti-rat IgG antibody. 
The level of Mac-1 expression was determined by flow  cytometry. 
(a)  Untreated WEHI-3B D+;  (b) control;  (c) 50 /~M cadmium 
chloride; (d) 10 ng/ml of rhG-CSF; (e) 50/~M cadmium chloride 
and 10 ng/ml of rhG-CSE 
fected cells were exposed to 10 ng/ml of G-CSF, however, 
60% or more of the D+GR cells exhibited a differentiated 
phenotype. In contrast, treatment of vector transfected cells 
or parental cells with the cytokine did not result in a major 
commitment to a differentiation pathway. RA induced essen- 
tially the same degree of differentiation in all instances, indi- 
caring that all of  the cell lines employed had the inherent abil- 
ity  to  differentiate  and  that  the  overexpression  of  the 
G-CSFR is necessary for the G-CSF induced differentiation 
of D+GR ceils. 
Immunofluorescent staining  of the  cell  surface antigen 
Mac-1 was employed as a second marker of the mature state 
to further confirm the differentiation status of D+GR cells 
induced by rhG-CSE After a 3-d exposure of these cells to 
rhG-CSF, cells were stained with monoclonal anti-Macq an- 
tibody and phycoerythrin-conjugated goat anti-rat IgG anti- 
body, and the level of Mac-1 was determined by flow cytome- 
try (Fig. 6).  A  broad Mac-1  positive peak appeared when 
D+GR cells were treated with rhG-CSF or cadmium plus 
rhG-CSF, whereas no such peak was observed in D+V vec- 
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Transfected  with the G-CSF Receptor Gene** 
NBT positivity 
Clone  Untreated  Cd  rhG-CSF  Cd + rhG-CSF 
% 
D+V3  0.7  +  0.2  1.8  •  1.2  0.5  +  0.4  1.3  +  0.8 
D+GR2  0.8  +  0.2  3.7  -k 4.5  42.9  +  15.7  43.5  +  12.8 
3  0.7  +0.2  1.5  +2.1  29.8  +4.6  45.2  • 
4  0.7  +0.2  1.3  •  60.9  •  14.2  77.3  •  6.6 
5  2.3  •  2.3  9.2  •  5.7  72.3  •  62.0•  18.0 
6  0.8  •  4.8  +0.8  51.3  +4.5  56.2  •  12.9 
7  0.3  •  0.5  •  46.2  •  15.9  51.5  •  15.8 
8  0.8  •  0.2  1.7  •  0.5  63.8  •  14.9  59.5  +  18.9 
9  0.2  •  2.7  •  3.1  27.0  •  34.7  •  3.7 
10  1.8  •  0.6  2.6  •  2.8  54.5  •  17.2  54.7  5:7.9 
11  0.8  •  0.8  0.3  •  0.5  9.3  •  1.9  21.2  •  4.6 
12  2.8  •  3.3  5.7  •  4.5  4.0  •  2.0  5.5  •  3.9 
13  0.5  +0.4  0.8  •  70.0  +  5.0  59.7  •  15.2 
14  8.5  •  1.5  3.2  •  2.1  59.8  •  12.3  59.7  •  21.5 
* Ceils were treated for 3 d with 50 pM CdCi2, 10 ng/ml of rhG-CSF, or the 
combination  thereof, and the percentage of NBT positive cells was determined 
as described in Materials and Methods. 
* Each value is the average of three independent experiments +  SD. 
tor control cells treated in an analogous manner. Quantifica- 
tion of the relative fluorescence intensity of the cells demon- 
strated  that  rhG-CSF or rhG-CSF  plus  cadmium  treated 
D+GR cells increased Mac-1  expression by 7.9- and 9.5- 
fold, respectively, over parental WEHI-3B D + cells. No cell 
adhesion  accompanied the  increase in  Mac-1  expression, 
suggesting  that cells were undergoing granulocytic matu- 
ration. 
Because (a) WEHI-3B D + cells, which have a relatively 
low number of G-CSFR and a relatively poor response to the 
differentiation inducing properties of G-CSF,  and  (b)  the 
overexpression of the G-CSFR converted the cells to highly 
responsive ones, we further investigated the relationship be- 
tween cell differentiation and the level of G-CSFR expres- 
sion in all of the selected D+GR clones. The 13 single cell 
clones were treated with cadmium, G-CSF, or their combi- 
nation for 3 d, and their capacity to reduce NBT was mea- 
sured and is shown in Table III. Except for D+GR12, all of 
the clones which had at least a fivefold increase in the expres- 
sion of the G-CSFR (Fig. 2) exhibited a significant degree 
of differentiation in response to G-CSF, confirming that the 
increased expression of the receptor results in an enhance- 
ment in the ability of ceils to enter the differentiation path- 
way. However, no strict relationship existed between the de- 
gree of differentiation and the absolute level of the G-CSFR. 
Clone D+GR12, which had a low concentration of G-CSFR 
mRNA and a  low level of [1esI]rhG-CSF  binding,  was not 
induced to differentiate by G-CSE Thus, this clone was simi- 
lar to parental cells in all of the aspects studied except for 
its resistance to G-418. 
The  sensitivities  of  D+V3  and  D+GR6  cells  to  the 
differentiation inducing capacity of  various concentrations of 
rhG-CSF were determined in  suspension  culture and the 
results are shown in Fig. 7. A concentration-dependent in- 
crease in the percentage of differentiated D+GR6 ceils was 
obtained, with more than 80 % of the cellular population ex- 
hibiting a differentiated phenotype at the highest concentra- 
tion ofrhG-CSF employed, whereas only 12 % ofD+V3 vec- 
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Figure 7. Concentration-dependent differentiation of D+GR6 ceils 
(m) induced by rhG-CSE  Cells were exposed to various concen- 
trations of the cytokine for 3 d and the percentage of NBT positive 
cells was determined as described in Materials and Methods. D+V3 
vector containing ceils (zx) were used as the control. Each point 
represents the average of three values +  SD. 
tor transfected cells expressed Nffr positivity at the highest 
level of rhG-CSF tested.  The concentration-dependent in- 
duction of differentiation in the clone expressing a high level 
of G-CSFR demonstrated that the differentiation-inducing 
effect is G-CSF specific. 
IL-3 is known to support the growth of 32D C13 cells and 
to antagonize the differentiation inducing effects of G-CSF 
in this cell line (35). Because WEHI-3B D + cells constitu- 
tively secrete IL-3 (12),  we conducted an experiment de- 
signed  to  provide  indirect  evidence  as  to  whether  the 
differentiation of D+GR cells was achieved through inhibi- 
tion of the secretion of IL-3 by the G-CSF signal transduc- 
tion pathway.  The assumption  was  made that if IL-3 an- 
tagonized  the  effects of G-CSF,  supplementation  of the 
medium by IL-3 would suppress G-CSF induced differentia- 
tion. However, no such interference with the maturation pro- 
duced by G-CSF in D+GR6 cells was observed when a con- 
centration of IL-3 up to 100 U/ml was employed (Table IV). 
Discussion 
G-CSF has been reported to be an inducer of the differentia- 
tion of WEHI-3B D + cells, assayed by culture in semisolid 
agar (5, 27). Under these conditions, granulocytic colonies 
were formed and the clonogenic activity of the cells was 
greatly reduced by G-CSE In contrast, Bthmer and Burgess 
(4)  have  reported  that  G-CSF  is  not  an  inducer  of the 
differentiation of WEHI-3B D + cells, but is required for the 
survival of mature progeny in suspension culture at low cell 
density. We have also found that G-CSF is not an effective 
initiator of the maturation of WEHI-3B D + cells, and only 
a small percentage of cells exhibited a differentiated pheno- 
type when exposed to a concentration of  the cytokine as high 
as 50 ng/ml in suspension culture (14). To gain a clear under- 
standing of the effects of G-CSF, we have examined the role 
of its receptor in the maturation process. This was accom- 
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of D+GR6 Induced by rhG-CSF* 
G-CSF  IL-3  NBT positivity 
(ng/ml)  (U/ml)  %  * 
0  0  0.3  +  0.3 
10  0  43.5  +  6.7 
10  1  47.2  +  1.3 
10  5  43.0  +  2.2 
10  20  42.5  +  4.8 
10  100  51.0  +  8.8 
* D+GR6 cells were treated for 3 d with 10 ng/mi of rhG-CSF in the absence 
or presence of various concentrations of IL-3. 
* Each value represents the mean +  SD of three separate flasks. 
plished by the introduction of the G-CSFR gene into WEHI- 
3B D § ceils and evaluation of the effects of the overexpres- 
sion of the receptor in both semisolid and suspension culture 
systems. In soft agar culture, 10 ng/ml of rhG-CSF produced 
a differentiated morphology in all of the colonies formed by 
the cloning of D+GR6 cells,  while only 26%  of parental 
cells were differentiated under the same conditions. In an 
analogous manner, in suspension culture, more than 60% of 
the cellular population exhibited a mature phenotype, even 
at relatively low concentrations of G-CSF in G-CSFR trans- 
fected cells, whereas about 6 % differentiation was seen in 
the vector transfected cells under identical conditions. Vec- 
tor transfected control cells showed a very slight increase in 
NBT positivity over that of parental cells when exposed to 
G-CSE It is unlikely that this increase is due to a specific 
selection of high G-CSFR expressing cells by G-418, but is 
probably due to the presence of residual nontransfected dy- 
ing cells after G-418 selection. 
A decrease in the growth rate accompanied the differen- 
tiated state. The decrease in growth was seen as early as 36 
h after exposure to G-CSF at a relatively low cell density (1 
x  10  s cells/ml); thus, no extensive cell-to-cell contact and 
no loss of the proliferation-stimulating activity of the FBS 
presumably occurred.  Therefore, it was  assumed that the 
differentiation and the decrease in growth rate were directly 
the result of the interaction between G-CSF and its receptor. 
These findings confirm the role of G-CSF and its receptor 
in the initiation of the differentiation process, and because 
excess  receptor was  required  to  initiate  maturation,  the 
findings appear to provide an example of a deficiency in the 
receptor portion of  the signal transduction mechanism in this 
malignant cell line that interfered with the capacity of the 
cytokine to function as a regulator of growth and differenti- 
ation. 
When  the  differentiation inducing  effects of G-CSF  on 
D+GR cells were compared to those of RA, the percentage 
of differentiated cells was found to be similar. However, the 
total number of cells exhibiting the differentiated phenotype 
was much greater with the cytokine, because when D+GR 
cells were exposed to RA or rhG-CSF, the cell density was 
much  lower  with  the  retinoid,  indicating  that  RA  is  a 
stronger inhibitor of growth than G-CSE Thus, the major 
role of G-CSF in this system appears to be the induction of 
differentiation. 
The dissociation constant for G-CSF and the number of 
binding  sites  for the cytokine on each WEHI-3B D + cell 
observed in the present study does not correspond to that of 
an earlier report (25). It is conceivable that these differences 
are due to the sources of the G-CSF that were utilized in the 
binding experiments. Murine native G-CSF was used in the 
early  study,  while  a  mutant  recombinant human  G-CSF 
(Tyrl,3-rhG-CSF) was employed in the present experiments. 
The mutation in this recombinant G-CSF does not affect the 
specificity of G-CSF for its receptor, and the cytokine still 
retains its biological activity after radioiodination (37). We 
have found, however, that a relatively high nonspecific bind- 
ing of Tyrl,3-rhG-CSF to WEHI-3B D § cells occurs under 
the experimental conditions employed, which may contrib- 
ute to the higher value that was obtained for the dissociation 
constant  and  the  number  of binding  sites  per  cell.  The 
G-CSFR transfected cells have the same level of nonspecific 
binding as the parental cells, but much higher specific bind- 
ing.  Considering the high specific binding and the results 
from the northern hybridization and cross-linking experi- 
ments, the values for the dissociation constant and the num- 
ber of G-CSFRs  present in  parental  WEHI-3B  D § cells, 
does not affect the overall interpretation of the effects of the 
overexpression of the  G-CSFR on the  differentiation and 
proliferation of WEHI-3B D § cells. 
Proliferation and differentiation are often opposing pro- 
cesses. G-CSF can both stimulate growth and induce differen- 
tiation, depending upon the cell line. With WEHI-3B D § 
M1,  32D C13  and HL-60 cells, the predominant effect of 
G-CSF may be to induce maturation (5,  17, 32), whereas in 
NFS60, AML-193 and OCI/AMLla cells, the major effect of 
the cytokine appears to be stimulation of growth, at least ini- 
tially (21,  30,  38). Overexpression of the G-CSFR gene in 
the IL-3 dependent murine myeloid cell line FDC-P1 and the 
pro-B cell line BAF-B03 enhances the proliferation of these 
cells in response to G-CSF, whereas the cytokine does not 
stimulate growth in the IL-2 dependent T cell line CTLL-2 
when  G-CSFR  is  overexpressed  (9).  We  have  used  the 
G-CSFR cDNA  originally cloned from NFS60 cells and 
have  obtained  a  different  effect  (i.e.,  differentiation)  in 
WEHI-3B  D §  cells,  confirming  that  the  same  protein, 
which mediates the stimulation of growth in NFS60 cells, in- 
duces differentiation in WEHI-3B D § cells. These findings 
indicate that the  signal  transduced in these two cell lines 
must differ after occupancy of the receptor. In this regard, 
it is worth noting that the c-myb and evi-1 genes, which may 
play important roles in differentiation, have been rearranged 
in NFS60 cells but not in WEHI-3B D § cells (19),  and that 
a greater degree of differentiation of AML-193 cells is ob- 
tained when G-CSF is used in combination with RA than 
with RA alone, although G-CSF itself sustains the growth of 
this cell line (34). 
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